Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.
Breast Cancer Res Treat
; 155(3): 597-601, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-26888723
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptor, ErbB-2
/
BRCA1 Protein
/
BRCA2 Protein
/
Triple Negative Breast Neoplasms
Type of study:
Clinical_trials
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2016
Type:
Article
Affiliation country:
United kingdom